All Companies Curbing Shipments of Meropenem, Top-Priority Drug Requiring Stable Supplies

August 23, 2022
All companies marketing the antibiotic meropenem in Japan have started to restrict or suspend shipments of the drug, which has been designated as one of the 21 top-priority “stable supply medicines” for which the securing of stable supplies is deemed...read more